17P Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations.

Saved in:
Bibliographic Details
Title: 17P Direct inhibition of RAS reveals the features of oncogenic signaling driven by RAS G12 and Q61 mutations.
Authors: Marasco, M.1 (AUTHOR), Kumar, D.2 (AUTHOR), Garcia Borrego, S.3 (AUTHOR), Seale, T.3 (AUTHOR), Maddalena, G.4 (AUTHOR), Mezzadra, R.5 (AUTHOR), Belanger, K.3 (AUTHOR), Cole, S.3 (AUTHOR), Perez, B.3 (AUTHOR), Luan, W.5 (AUTHOR), Arena, S.6 (AUTHOR), Bardelli, A.7 (AUTHOR), de Stanchina, E.8 (AUTHOR), Lowe, S.W.5 (AUTHOR), Burkhart, R.3 (AUTHOR), Zimmerman, J.W.3 (AUTHOR), Yaeger, R.9 (AUTHOR), Kopetz, S.10 (AUTHOR), Rosen, N.2 (AUTHOR), Misale, S.3 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS214-S214. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.454